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Abstract. The spatial and temporal expression pattern 
of the muscle regulatory gene Myf-6 (MRF4/herculin) 
has been investigated by in situ hybridization during em- 
bryonic and fetal mouse development. Here, we report 
that the Myf-6 gene shows a biphasic pattern of expres- 
sion. Myf-6  transcripts are first detected in the most ros- 
tral somites of the mouse embryo at 9 d of gestation 
and accumulate progressively in myotomal cells along 
the rostro-caudal axis.  This expression is transient and 
Myf-6 mRNA can no longer be detected in myotomal 
cells after day 12 post coitum (p.c.). In contrast to other 
muscle determination genes (MyoD1, myogenin, Myf-5), 
Myf-6 mRNA is not detected in limb buds or visceral 
arches and skeletal muscle of the mouse embryo (day 
8-15 p.c.). In fetal mice, Myf-6  transcripts appear at day 
16 p.c.  in all skeletal muscles, and the gene continues 
to be expressed at a high level after birth. These results 
suggest that early Myf-6 expression may be restricted 
to a population of myogenic cells that does not contrib- 
ute to the embryonic muscle masses in limb buds and 
visceral arches.  The reappearance of Myf-6 mRNA 
in fetal skeletal muscle coincides approximately with 
secondary muscle fiber formation and the onset of 
innervation. 
T 
HE isolation of MyoD1,  the first muscle regulatory 
protein, from the C3H mouse myogenic cell line 10T1/2 
(Davis et al., 1987) was followed by the identification 
of three additional, related but distinct proteins from various 
species.  Myogenin (Wright et al.,  1989;  Edmondson and 
Olson,  1989;  Braun et al.,  1989a),  Myf-5 (Braun et al., 
1989b), and MRF4 (rat) (Rhodes and Konieczny, 1989), also 
called Myf-6 (human)  (Braun  et  al.,  1990)  and herculin 
(mouse) (Miner and Wold, 1990), are all members of a fam- 
ily of  muscle-specific helix-loop-helix proteins whose forced 
expression leads to the muscle phenotype in 101"1/2 mouse 
fibroblasts (for review see Olson,  1990).  In nonfibroblast 
cell types, regulators in addition to the helix-loop-helix pro- 
teins appear to be required to induce a phenotypic conversion 
to muscle (Weintraub et al.,  1989).  In transfection experi- 
ments using vectors that constitutively express the four myo- 
genic factors, transcriptional activation of muscle-specific 
reporter genes has been demonstrated for each factor (Lin 
et al.,  1989;  Edmondson and Olson,  1989;  Yutzey et al., 
1990; Braun et al., 1990a). Autoactivation  of  the correspond- 
ing endogenous genes and cross-activation of the other mem- 
bers of the gene family have also been shown (Braun et al., 
1989b;  Thayer et al.,  1989).  Furthermore, heterodimeriza- 
tion properties and DNA binding affinities in vitro have been 
studied and found to be similar for the human Myf proteins 
(Braun,  T.,  and H.  H.  Arnold, manuscript submitted for 
publication; Rosenthal et al.,  1990),  suggesting that these 
proteins may have similar if not identical functions. 
The first indication that these proteins may play distinct 
roles during myogenesis in vivo came from in situ hybrid- 
ization experiments performed on mouse embryo sections. 
These studies showed that MyoD and myogenin mRNAs have 
different temporal patterns of accumulation in the myotome 
and in the developing limb bud (Sassoon et al., 1989). More 
recently, we have reported that Myf-5 mRNA expression is 
detectable in somites before myotome formation and clearly 
precedes the expression of myogenin and MyoD1 (Ott et al., 
1991). In contrast to the expression of the latter two factors 
which, once initiated, continue to accumulate in all develop- 
ing skeletal muscles, Myf-5 is transiently activated in an an- 
terior posterior gradient but is down-regulated in limb and 
body muscle from 11.5 d p.c.  (Ott et al.,  1991). The early 
expression of Myf-5 in dermamyotomal cells may indicate its 
involvement in the determination of myoblasts rather than in 
the establishment of terminally differentiated muscle ceils. 
The expression pattern of the fourth myogenic factor of 
this family, Myf-6  (MRF4, herculin) during mouse develop- 
ment has not been described. Rhodes and Konieczny (1989) 
reported the first detection of MRF4 mRNA by Northern blot 
analysis in the skeletal muscle of a rat fetus at 18 d p.c. Here, 
we describe the detailed analysis of Myf-6 expression during 
mouse embryogenesis using in situ hybridization. We com- 
pare the time course of Myf-6 mRNA synthesis with that of 
other Myf genes. It is particularly interesting to compare the 
expression of Myf-5 and Myf-6 transcripts since both genes 
are closely linked on human chromosome 12 (Braun et al., 
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Figure 1. Nucleotide sequence of the 
mouse Myf-6 cDNA. The mouse se- 
quence is compared to the homolo- 
gous cDNAs from rat (MRF4) and 
human  (hMyf-6).  Identical  nucleo- 
tide residues are indicated by dashes. 
Dots indicate gaps  which have been 
introduced  for  optimal  alignment. 
Start  and  stop  codons  are  marked 
by  asterisks.  The fragment used as 
hybridization  probe  is  underlined. 
These  sequence  data  are  available 
from EMBL/GenBank/DDBJ under 
accession numbers X51591, X51592, 
and  )(51593. 
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We show that Myf-6 has a biphasic pattern of expression in 
embryonic and fetal mouse skeletal muscle. 
Materials and Methods 
Isolation and Nucleotide Sequence Determination of 
the Mouse Myf-6 cDNA 
The Myf-6 cDNA was  isolated by screening  1  x  106 p.f.u,  of a  phage 
larnbda gt-ll library prepared from skeletal muscle of a newborn mouse 
(kind gift of J.  P.  Merlie, Washington University,  St.  Louis,  MO).  The 
probe was derived from the first exon of the human Myf-6 gene and is repre- 
sented by a 160-bp Pstl fragment that lacks homology to other myfcDNAs 
(Braun et al., 1990a).  The largest of three independent cDNA isolates was 
sequenced by the dideoxy  chain termination method (Sanger et al.,  1977) 
on both strands using subcloned restriction fragments and nested deletions 
(Henikoff,  1984). 
Northern Blot Analysis 
Total RNA was prepared from limbs and trunks of mouse embryos and fe- 
tuses staged between days 12 to 19 p.c., and from newborn and adult mouse 
limb skeletal muscle by the LiCl/urea method (Auffray and Rougeon,  1980). 
Gel electrophoresis,  RNA transfer,  and hybridization conditions have been 
described (Braun et al., 1989a). The probes for Northern blot analysis were 
DNA fragments corresponding to the 3'-specific regions of myogenin (Sas- 
soon et al., 1989), and Myf-6 cDNAs as described for cRNA probes used 
for in situ hybridizations.  DNA was labeled to a specific activity of 1-3  × 
10  s cpm//~g using the multiprime labeling kit from Amersham International 
(Amersham, UK). 
Preparation and Prehybridization of Tissue Sections 
C3H and BALB/c mouse embryos and fetuses were fixed and embedded as 
described previously (Lyons et al., 1990). Tv~ sections were mounted per 
slide. 
Preparation of  Probes  for In Situ Hybridization 
Restriction fragments, which specifically detect Myf-5, Myf-6, and myogenin 
transcripts were subcloned into the Bluescribe transcription vector (Strata- 
gene Cloning Systems,  La Jolla, CA) and grown in E. coli TG1. For the 
Myf-6 probe, the 680-bp 3~PstI fragment indicated in Fig.  1 was used.  The 
Myf-5 probe is a 310-bp BalI-ApaI fragment of the first exon of the mouse 
Myf-5 gene as described in Oft et al. (1991). The myogenin probe corre- 
spends to the 3'-terminal 700-bp of the rat myogenin eDNA (Wright et al., 
1989; Sassoon et al., 1989). The cRNA transcripts were synthesized accord- 
ing to manufacturer's  conditions (Stratagene Cloning Systems), and labeled 
with 35S-UTP (>1,000  Ci/mmol; Amersham International). cRNA tran- 
scripts were partially hydrolyzed to a mean size of  70 nucleotides for efficient 
hybridization. 
Hybridization and Washing Procedures 
Hybridization and washing  procedures were performed as described in 
Lyons et al. (1990). Slides were dipped in undiluted Kodak NTB-2 nuclear 
track emulsion and exposed for 1 wk at 4°C. Slides were developed in Kodak 
D-19 and analyzed using light- and dark-field optics of a Zeiss Axioplan or 
Axiophot microscope. 
Results 
Using the human Myf-6 eDNA (Braun et al., 1990a)  as hy- 
bridization probe,  we have isolated the almost full-length 
mouse Myf-6homologue which corresponds to the previously 
described herculin gene (Miner and Wold, 1990).  As shown 
in Fig.  1,  the nucleotide sequence of the mouse cDNA is 
highly conserved and has diverged •10  and 20% from MRF4 
rat and Myf-6  (human) sequences, respectively (Braun et al., 
1990a; Rhodes and Konieczny, 1989).  A high degree of se- 
quence conservation exists even in the untranslated regions 
of the eDNA, which was used to generate the Myf-6-specific 
complementary  RNA probe, encoded  by a 680-bp PstI restric- 
tion fragment. It was cloned behind the T7 promoter in the 
pBS vector (Stratagene Cloning Systems). The specificity 
of the probe was determined on a Northern blot (data not 
shown). In embryonic (day 8-15 p.c.) and fetal (day 15-19 
p.c.) limb and trunk RNA preparations from mice, Myf-6 
mRNA was first detected on Northern blots at day 16 p.c. 
with continued expression into the postnatal period. In con- 
trast, myogenin mRNA was already weakly present in 12-d 
embryos in both limb and trunk, and was found to be reduced 
Figure 2. Northern blot analysis: expression of Myf-6 and myogenin RNA in limb buds (L) and trunks (T) of mouse embryos and fetuses 
from 12-19 d p.o.  Hybridization probes were prepared as described in Materials and Methods. NB,  newborn limb and trunk.  NY,  10 d 
postnatal limb. 
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vation confirmed the result obtained for the rat MRF4 expres- 
sion which also showed late onset in development (Rhodes 
and Konleczny, 1989). 
To investigate Myf-6  expression in more detail, mouse em- 
bryos between 9 and 11.5 d p.c. were sectioned and hybrid- 
ized in situ with various Myf probes. As shown in Fig. 3, in 
transverse sections of two embryos of 9 (18 somites; Rugh, 
1990) and 9.5 d (24 somites) p.o., we detected the accumula- 
tion of both Myf-5 and Myf-6  transcripts on serial slides of 
rostral somites. Myf-5  transcripts can first be detected in the 
newly formed somites at day 8 (Ott et al.,  1991), whereas 
Myf-6transcripts are first seen at day 9 p.o. These transcripts 
gradually accumulate as shown in a transverse section of a 
9.5-d p.c.  embryo (Fig. 3). 
To extend the analysis to later stages of  development, para- 
sagittal and transverse sections were performed on two ll-d- 
old littermates (39-44 somites). Serial sections were hybrid- 
ized to Myf-5, Myf-6, and myogenin probes. To ascertain that 
somites were cut in the appropriate plane, slides chosen for 
hybridization  with the Myf-  6 probe were sandwiched  between 
slides which were hybridized to the other probes (Myf-5 and 
myogenin). At least two sections were probed on each slide. 
As shown in Fig. 4, a-c, in parasagittal sections of a region 
slightly anterior to the hind limb bud, somites expressed ap- 
proximately equal levels ofMyf-6, Myf-5, and myogenin  tran- 
scripts. In the limb bud itself, Myf-5  mRNA was abundantly 
expressed (Fig. 4 a), but myogenln and Myf-6  mRNAs were 
not detected. In parasagittal sections of more posterior so- 
mites, again, similar levels of all three transcripts, Myf-5, 
Myf-6, and myogenin were observed (Fig. 4, d-f). In ad- 
jacent somites, we detected coexpression of Myf-5 and myo- 
genin at relatively high levels, but no Myf-6 mRNA. The 
most caudal and therefore least developed somites immedi- 
ately adjacent to the neural tube (Fig. 4 d), however, hybri- 
dized exclusively to the Myf-5  probe, confirming that Myf-5 
expression precedes that of the other members of the MyoD 
gene family. This series of hybridizations shows that the acti- 
vation of the Myf-6  gene, like that of other myogenic factor 
genes, follows a rostro-caudal gradient. Each myogenic reg- 
ulatory factor gene follows a distinct temporal sequence of 
activation in the somites during embryonic development. 
The onset of Myf-6  expression lags slightly behind the ini- 
tial detection of myogenln transcripts, but the relative levels 
of  both mRNAs are approximately equal at a later stage (Fig. 
4). As myotomes develop, the level of Myf-6 mRNA starts 
to decline in comparison to that of myogenin mRNA. The 
rostro-caudal gradient of the decrease in Myf-6  mRNA con- 
centration is demonstrated in serial transverse sections of an 
ll.5-d-old embryo in the forelimb bud region. At this time 
of development, the more rostral somites contain less Myf-6 
mRNA compared to that of  myogenin, while the more caudal 
somites still express high levels of Myf-6 mRNA (Fig. 5). 
We did not detect Myf-6 transcripts between day 12 and 
15 p,c.  (data not shown) by in situ hybridization, which is 
consistent with the results obtained by Northern blot analysis 
(see Fig. 2). In conclusion, these results together with those 
shown in Fig. 4 indicate that the Myf-6 gene is transiently 
activated in myotomes during somitogenesis, and that the in- 
activation of Myf-6  procedes in the same anterior-posterior 
gradient as activation. 
Although Myf-6mRNA is detected between 9 and 12 d p.c. 
in developing myotomes, in situ hybridization performed on 
limb buds and visceral arches in embryos of the same age 
shows that Myf-6  mRNA is never detected in these structures. 
For example, Fig. 6, a-c shows the limb bud of an ll.5-d-old 
embryo, demonstrating hybridization of  myogenin  and Myf-5 
mRNA,  but  not detectable hybridization with the Myf-6 
probe. Fig. 6, d-f shows the mandibular arch of an lid p.c. 
embryo.  There again Myf-6 transcripts  are  not detected, 
whereas Myf-5 is expressed at high levels and myogenln at 
low but detectable levels.  Similar results were obtained at 
different stages of embryogenesis (data not shown). 
The time of transient Myf-6  and Myf-5 expression in so- 
mites is presumably followed by a period when only myo- 
genin and MyoD1 mRNA are detected in myotomal cells as 
previously shown by OR et ai. (1991) and our results (Fig. 
7). To examine Myf-6  mRNA accumulation at later stages, 
we extended the analysis up to fetal stages (15-19 d p.c.). As 
shown in Fig. 7, body wall muscles of a 17.5-d fetus contain 
high levels of Myf-6  transcripts as well as myogenin mRNA. 
At this time, Myf-5 transcripts can no longer be detected 
(data not shown; Ott et al., 1991). From these observations 
we conclude that the Myf-6  gene becomes reactivated in fetal 
skeletal muscle where it is coexpressed with MyoD1  (data 
not shown) and myogenln. Tables I and 1I summarize the re- 
sults for in situ hybridization with each of the myogenic fac- 
tor probes in developing embryonic myotomes, limb buds, 
and visceral arches. 
Discussion 
The detailed analysis of Myf-6  transcripts in mouse embryos 
performed by in situ hybridization completes a series of in- 
vestigations on the temporal and spatial expression pattern 
of those muscle regulatory genes which have been identified 
so far. The results confirm that the expression of  all members 
of the MyoD family is restricted to skeletal muscle cells and 
their precursors. Synthesis is not detected in the heart at any 
time of  development. The tissue and cell types expressing the 
four genes appear to be identical or at least extensively over- 
lapping, although the temporal pattern of these gene activ- 
ities are quite distinct. Myf-5  is the first gene that is activated 
in dermamyotornal cells of newly formed somites before the 
differentiation  of  dermatome and myotome (Ott et al., 1991). 
Transcription of myogenin and Myf-6 genes is initiated, in 
this order, in more mature somites 12-24 h later when myo- 
tomal cells have formed. The onset of  MyoD1 expression fol- 
lows •24  h later (Sassoon et ai.,  1989).  The activation of 
the genes encoding the  muscle regulatory factors occurs 
Figure 3. Myf-6  mRNA first appears in 9 d p.c. embryos and accumulates in developing myotomes. Transverse sections of an 18 somite 
embryo hybridized to the Myf-5  probe (a and c) and the Myf-6  probe (b). Transverse sections of a 24 somite embryo (9.5 d p.o.) hybridized 
with the Myf-6  probe (d and e) and the Myf-5 probe (f); a and d are phase contrast micrographs, b, c, e, and fare dark field micrographs. 
Myotomes are indicated by arrowheads. NT, neural tube. Bars: (a-c) 120 ttm; (d-f) 240 ~m. 
Bober et al. Biphasic Expression of Myf-6 in Muscle Development  1259 Figure 4.  Myogenic factors follow a distinct pattern of gene activation during embryonic development. Serial sections at the level of the 
hindlimb bud of an 11 d p.c. (39--44  somites) embryo were hybridized to the probe for Myf-5 (a), Myf-6 (b), and myogenin (c). More 
caudal sections of the same embryo as in a-c were hybridized with the probes for Myf-5 (d), Myf-6 (e), and myogenin (f). NT, neural 
tube; L, limb bud. Bars: (a-c) 200/~m;  (d-f) 250/~m. 
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lated in a rostro~audal gradient. Parallel transverse sections of an 
11 d p.o. embryo (39-44 somites) were hybridized to probes in the 
following  order: Myf-5 (a), Myf-6  (b), and myogenin  (c). FL, fore- 
limb bud. Some myotomes are indicated by arrowheads. Bar: (a-c) 
120/~m. 
along  the  same  rostro-caudal  gradient  as  somitogenesis. 
Therefore, the critical parameter for gene activation appears 
to be the developmental stage of the somites. 
There is no indication in vivo of the rapid reciprocal acti- 
vation phenomenon seen between myogenic factors in cell 
transfection experiments. Any such phenomenon acting in 
the somites is more subtle. The initial kinetics of expression 
might suggest that Myf-5 activates myogenin which activates 
Myf-6, and that activation of MyoD1 has a negative effect on 
the initial wave of Myf-6 expression and subsequently on 
Myf-5. However, what happens in the limb and what happens 
in fetal muscle when Myf-6 expression reappears suggests 
that any such regulatory circuits between myogenic factors, 
if they exist in vivo, are subject to extrinsic modifications. 
It was recently shown by Lyons et al. (1990) that mRNAs 
encoding different  isoforms of  both cardiac and skeletal mus- 
cle myosin heavy chains and myosin light chains are first de- 
tected between 9 and 10 d p.o. in the myotomes of the most 
rostral somites and appear in more caudal somites at later 
stages. If, as suggested for the other myogenic factors (see 
Olson, 1990 for review) and shown in terms of a transcrip- 
tional activation  domain for Myf-5  (Braun et al. 1990b), these 
proteins act as transcription factors for muscle-specific  genes, 
Myf-6 could be involved in the activation of these myosin 
genes, since its transcription starts approximately at the same 
time of development. However,  in tissue culture cells there 
appears to be no simple pattern of coordinated activation be- 
tween muscle regulatory genes and structural protein genes 
(Miller,  1990).  There rather may be cooperation between 
one or more of the myogenic factors and positive or negative 
general transcription factors, such as El2 (Murre et al., 1989) 
and Id (Benezra et al., 1990), and this may determine the ex- 
pression patterns of muscle structural genes. 
In addition to their expression in the myotome, initially 
Myf-5, and slightly later myogenin  and MyoD are transcribed 
in myogenic  cells which have migrated into the limb buds and 
visceral arches (Sassoon et al.,  1989;  Ottet al.,  1991). We 
have also observed the expression of  these three factors in the 
developing extraocular muscles (Lyons, G. E., and E. Bober, 
unpublished observations). Within the limits of detection of 
the in situ hybridization technique, Myf-6 is not expressed 
in these embryonic structures. These results are particularly 
interesting because they suggest either that different popula- 
tions of myogenic precursor cells exist in somites or that 
extrinsic factors which are involved in the initiation of the 
myogenic program are different for myotomal cells when 
compared to myogenic cells which have migrated away from 
the somite. Myotomal cells are thought to arise from a dif- 
ferent portion of the differentiating somite than the cells that 
migrate out to form muscle in axial structures. Cells from 
the dorsomedial lip (Ede and EI-Gadi,  1986)  or from the 
cranial edge (Kaehn et al., 1988) of the dermamyotome mi- 
grate underneath the dermatome to form the myotome. How- 
ever, cells from  the ventrolateral  edge  of  the somite  are thought 
to migrate out to developing limb buds before myotome for- 
mation (Jacob et al.,  1979;  Milaire,  1976). 
Little is known about the physiological signals that influ- 
ence skeletal muscle differentiation  in embryos. As myotomes 
form and muscle gene transcripts begin to accumulate, pro- 
cesses from the neural tube have been observed to contact 
the myotomal cells (Filogamo and Gabella, 1967).  Vivarelli 
and Cossu (1986) have shown that the presence of the neural 
Bober et al. Biphasic Expression of Myf-6 in Muscle Development  1261 Figure 6. Myf-6 mRNAs are not detected in embryonic limb buds and visceral arches. Serial sections of the forelimb bud of an 11.5 d 
p.c. embryo were hybridized with probes for Myf-5 (a), Myf-6 (b),  and myogenin (c). Sections of the mandibular arch of an 11.5 d p.o. 
embryo were hybridized to the probes for Myf-5 (d), Myf-6 (e), and myogenin (f). D, dorsal premuscle mass; V, ventral premusele mass. 
Bars: (a-c) 240/~m;  (d-f)  120/~m. 
tube in cultures of 8.5 d p.c.  somitic cells is essential for the 
appearance of myosin-positive cells, but in cultures of 10.5 d 
p.c.  somites, the number of myosin-positive cells appearing 
is largely independent of  the neural tube. Since the four myo- 
genie regulatory factor genes are activated between 8 and 
10.5 d p.c., the influence of the neural tube may be essential 
at least for the initiation of the myogenic program in myo- 
tomal cells. 
In contrast,  premyogenic cells  that migrate to the limb 
buds and visceral arches are not in close proximity to the 
The Journal of Cell Biology,  Volume 113, 1991  1262 Figure 7. Myf-6 is reexpressed in fetal skeletal muscles. Transverse sections of the body wall muscles of a 17.5 d p.c. fetus were hybridized 
with the probes for Myf-6 (a) and myogenin (b). Bar: (a and b) 200 #m. 
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in Embryonic Mouse Somites 
Embryo 
age 
Rostral myotomes  Caudal myotomes 
Myf-5  Myogenin  Myf-6  MyoD~ Myf-5  Myogenin  Myf-6  MyoD 
8.0  +  -  -  - 
8.5  ++  ++  -  -  +  -  -  - 
9fi  ++  +++  +  -  ++  ++  -  - 
1~5  ++  +++  ++  +  ++  +++  +  - 
ll.O  ++  +++  +  ++  ++  +++  ++  + 
11.5  +  +++  -  +++  ++  +++  +  ++ 
12~  +  +++  -  +++  +  +++  -  +++ 
13.0  -  +++  -  +++  +  +++  -  +++ 
14.0  -  +++  -  +++  -  +++  -  +++ 
* Myf-5 is first detected in dermamyotomes and later in myotomes of develop- 
ing somites (Ott et al.,  1991). 
Sassoon et al.  (1989); Lyons, G. E., and M. Buckingham, unpublished ob- 
servations. 
neural tube except for a short time before migration.  These 
cells do not express detectable levels  of myogenic  factor 
transcripts  during their migration and for at least 24 h in the 
developing limb bud (Sassoon et al., 1989; Lyons, G. E., and 
M. Buckingham,  unpublished observations). For these cells, 
other extrinsic  factors may influence the onset of the myo- 
genic program and the pattern of myogenic factor gene ex- 
pression.  For example,  the  accumulation  of extraeellular 
matrix components involved in the condensation  of chondro- 
genie cells and the redistribution  of premyogenic  cells into 
the regions of dorsal and ventral premuscle mass formation 
may be one process which influences the onset of the myo- 
genic program in semite-derived ceils. In contrast,  mitogens 
that are enriched in developing limb buds may delay muscle 
differentiation. 
Considering the developmental time span during which the 
muscle regulatory genes are actively transcribed,  two general 
patterns  can be distinguished.  One, exhibited by Myf-5 and 
Myf-6, is characterized  by transient embryonic expression in 
somites, and in the case of Myf-5, in limb buds and visceral 
arches. The other, exhibited by myogenin and MyoD, is a pat- 
tern of continued expression in embryonic and in fetal mus- 
cle. The different timing of the onset of Myf-5 and Myf-6gene 
Table 2. Expression of  Myogenic Factors in Embryonic 
Limb Buds and Visceral Arches 
Embryo 
age 
Forelimb buds and 
visceral arches  Hindlimb buds 
Myf-5  Myogenin  Myf-6  MyoD*  Myf-5  Myogenin  Myf-6  MyoD 
d.p.c. 
9.5  .... 
10.5  +  -  -  - 
11.0  ++  ++  -  ++  +  - 
11.5  +  ++  -  ++  ++  ++ 
12.0  +  +++  -  +++  +  +++ 
13.0  -  +++  -  +++  +  +++ 
14.0  -  +++  -  +++  -  +++ 
-  ++ 
-  +++ 
--  +++ 
--  +++ 
* Sassoon et al. (1989); Lyons, G. E., and M. Buckingham, unpublished ob- 
servations. 
Myf-5 is detected in the visceral arches at this stage but not in forelimb buds 
(Ott et al.,  1991). 
activation in somites and also their slightly different pattern 
of down regulation argues against a common regulatory con- 
trol of both genes despite their close linkage in the genome. 
This is further supported by the differential regulation of  both 
genes in extrasomitic structures. Finally, in contrast to the 
M~f-5 gene which is expressed in one wave from day 8 to 
day 13 p.c. of embryonic development,  Myf-6 exhibits a bi- 
phasic pattern of expression.  The first phase lasts from 9 to 
11.5 d p.e. in myotomes, and the second phase begins around 
16 d p.c. in fetal skeletal muscle with expression continuing 
into adult muscle. 
The reappearance of  Myf-6transcripts in fetal skeletal mus- 
cle occurs at approximately  the same time as the beginning 
of  the formation of secondary muscle fibers and the establish- 
ment of  neuromuscular junctions (Ontell and K_ozeka, 1984). 
Thus at least the initiation of Myf-6 expression in fetal skel- 
etal muscle may be controlled by innervation.  Experiments 
on mouse embryos denervated in utero should provide fur- 
ther information. 
In conclusion,  the analysis of the patterns of expression of 
the four related  myogenic  factor genes Myf-5, myogenin, 
Myf-6, and MyoD during  embryonic and fetal development 
in the mouse indicates that each of these genes follows a dis- 
tinct time course of activation,  accumulation  and inactiva- 
tion. This pattern is different in two populations of myogenic 
cells, those in myotomes and those in other structures in the 
embryo. These results provide a basis for further investiga- 
tion of which signals and which genes may be involved in the 
control of the muscle-specific  regulators. 
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